ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEIS) OR ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR): A META-ANALYSIS

Authors
Category Systematic review
JournalJournal of the American College of Cardiology
Year 2022
This article has no abstract
Epistemonikos ID: 0b2b2b4583165cedd8d73e46a4c19341ab7f7457
First added on: Feb 13, 2025